Acorah Software Products - Accounts Production 15.0.600 false true 31 March 2023 1 April 2022 false 1 April 2023 31 March 2024 31 March 2024 11796844 Mr R Lomax Mrs S Lomax iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11796844 2023-03-31 11796844 2024-03-31 11796844 2023-04-01 2024-03-31 11796844 frs-core:CurrentFinancialInstruments 2024-03-31 11796844 frs-core:ComputerEquipment 2024-03-31 11796844 frs-core:ComputerEquipment 2023-04-01 2024-03-31 11796844 frs-core:ComputerEquipment 2023-03-31 11796844 frs-core:RevaluationReserve 2023-04-01 2024-03-31 11796844 frs-core:RevaluationReserve 2023-03-31 11796844 frs-core:RevaluationReserve 2024-03-31 11796844 frs-core:ShareCapital 2024-03-31 11796844 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 11796844 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 11796844 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 11796844 frs-bus:SmallEntities 2023-04-01 2024-03-31 11796844 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 11796844 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 11796844 frs-core:DeferredTaxation 2023-04-01 2024-03-31 11796844 frs-core:DeferredTaxation 2023-03-31 11796844 frs-core:DeferredTaxation 2024-03-31 11796844 frs-core:UnlistedNon-exchangeTraded 2024-03-31 11796844 frs-core:UnlistedNon-exchangeTraded 2023-03-31 11796844 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-03-31 11796844 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 11796844 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 11796844 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-03-31 11796844 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-03-31 11796844 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 11796844 frs-bus:Director1 2023-04-01 2024-03-31 11796844 frs-bus:Director2 2023-04-01 2024-03-31 11796844 frs-countries:EnglandWales 2023-04-01 2024-03-31 11796844 2022-03-31 11796844 2023-03-31 11796844 2022-04-01 2023-03-31 11796844 frs-core:CurrentFinancialInstruments 2023-03-31 11796844 frs-core:RevaluationReserve 2023-03-31 11796844 frs-core:ShareCapital 2023-03-31 11796844 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31
Registered number: 11796844
Leeds Foot And Ankle Clinic Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 11796844
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 273 571
Investments 5 60,190 18,967
60,463 19,538
CURRENT ASSETS
Debtors 6 12,576 9,619
Cash at bank and in hand 113,790 86,602
126,366 96,221
Creditors: Amounts Falling Due Within One Year 7 (39,113 ) (20,026 )
NET CURRENT ASSETS (LIABILITIES) 87,253 76,195
TOTAL ASSETS LESS CURRENT LIABILITIES 147,716 95,733
PROVISIONS FOR LIABILITIES
Deferred Taxation 8 (52 ) (108 )
NET ASSETS 147,664 95,625
CAPITAL AND RESERVES
Called up share capital 10 4 4
Revaluation reserve 11 10,004 (1,099 )
Profit and Loss Account 137,656 96,720
SHAREHOLDERS' FUNDS 147,664 95,625
Page 1
Page 2
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr R Lomax
Director
29/07/2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Leeds Foot And Ankle Clinic Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11796844 . The registered office is 3 The Avenue, Horsforth, Leeds, LS18 5JW.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Computer Equipment 25% straight line
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences.

3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
4. Tangible Assets
Computer Equipment
£
Cost
As at 1 April 2023 1,192
As at 31 March 2024 1,192
Depreciation
As at 1 April 2023 621
Provided during the period 298
As at 31 March 2024 919
Net Book Value
As at 31 March 2024 273
As at 1 April 2023 571
Page 3
Page 4
5. Investments
Unlisted
£
Cost
As at 1 April 2023 18,967
Additions 30,120
Revaluations 11,103
As at 31 March 2024 60,190
Provision
As at 1 April 2023 -
As at 31 March 2024 -
Net Book Value
As at 31 March 2024 60,190
As at 1 April 2023 18,967
6. Debtors
2024 2023
£ £
Due within one year
Trade debtors 12,576 9,619
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Corporation tax 35,097 13,626
Accruals and deferred income 2,572 2,661
Directors' loan accounts 1,444 3,739
39,113 20,026
8. Deferred Taxation
The provision for deferred tax is made up as follows:
2024 2023
£ £
Other timing differences 52 108
9. Provisions for Liabilities
Deferred Tax Total
£ £
As at 1 April 2023 108 108
Deferred taxation (56 ) (56 )
Balance at 31 March 2024 52 52
Provision is made for the potential charge to tax that would arise should the company dispose of its fixed assets at the stated net book value to the extent that this is in excess of the tax written down value.
Page 4
Page 5
10. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 4 4
11. Reserves
Revaluation Reserve
£
As at 1 April 2023 (1,099 )
Transfer to profit and loss 11,103
As at 31 March 2024 10,004
Page 5